These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The role of cholinergic supersensitivity in the medical symptoms associated with withdrawal of antipsychotic drugs. Luchins DJ; Freed WJ; Wyatt RJ Am J Psychiatry; 1980 Nov; 137(11):1395-8. PubMed ID: 6108078 [TBL] [Abstract][Full Text] [Related]
4. Neuroleptic withdrawal. Maisami M; Golant D J Am Acad Child Adolesc Psychiatry; 1991 Mar; 30(2):336. PubMed ID: 1673122 [No Abstract] [Full Text] [Related]
5. Rebound insomnia in neuroleptic drug withdrawal neurophysiologic characteristics. van Sweden B Pharmacopsychiatry; 1987 May; 20(3):116-9. PubMed ID: 2885865 [TBL] [Abstract][Full Text] [Related]
6. Cholinergic rebounds and withdrawal syndromes. Pary RJ; Klontz W; Foxworth JM Am J Psychiatry; 1980 Feb; 137(2):261. PubMed ID: 7352599 [No Abstract] [Full Text] [Related]
7. Neuroleptic malignant syndrome related to a switch to perospirone and anticholinergic withdrawal. Tanii H; Fujita K; Okazaki Y Am J Psychiatry; 2006 Mar; 163(3):547-8. PubMed ID: 16513884 [No Abstract] [Full Text] [Related]
8. Neuroleptic malignant syndrome precipitated by haloperidol following clozapine discontinuation. Mendhekar DN; Jiloha RC Aust N Z J Psychiatry; 2005 Oct; 39(10):947-8. PubMed ID: 16168023 [No Abstract] [Full Text] [Related]
9. REM-latency in neuroleptic drug withdrawal. A case report. Van Sweden B Acta Psychiatr Belg; 1984; 84(3):235-9. PubMed ID: 6148841 [TBL] [Abstract][Full Text] [Related]
10. Neuroleptic malignant syndrome and clozapine withdrawal at the same time? Margetić B; Aukst-Margetić B Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):145-7. PubMed ID: 15610957 [TBL] [Abstract][Full Text] [Related]
11. [Changes in the number of benzodiazepine receptors in different parts of the brain of rats after neuroleptic withdrawal]. Zharkovskiĭ AM; Zharkovskaia TA Biull Eksp Biol Med; 1984 Oct; 98(10):457-9. PubMed ID: 6149778 [TBL] [Abstract][Full Text] [Related]
13. Atypical antipsychotics: CATIE study, drug-induced movement disorder and resulting iatrogenic psychiatric-like symptoms, supersensitivity rebound psychosis and withdrawal discontinuation syndromes. Chouinard G; Chouinard VA Psychother Psychosom; 2008; 77(2):69-77. PubMed ID: 18230939 [No Abstract] [Full Text] [Related]
14. Recurrence of hyperglycemic-induced chorea-ballismus after haloperidol withdrawal. Kim YD; Kim JS; Song IU; Lee KS; Kim YI Can J Neurol Sci; 2011 Jul; 38(4):663. PubMed ID: 21672711 [No Abstract] [Full Text] [Related]
15. [The neuroleptic malignant syndrome]. Duarte J; García Viejo MA; García Miguel FJ; Sempere AP Med Clin (Barc); 1994 Oct; 103(14):558. PubMed ID: 7799673 [No Abstract] [Full Text] [Related]
17. Use of "addictive" to describe neuroleptic drugs. McCormick S Am J Psychiatry; 1989 Sep; 146(9):1239-40. PubMed ID: 2569841 [No Abstract] [Full Text] [Related]
18. Neuroleptic withdrawal with remitted schizophrenics: a naturalistic follow-up study. Nishikawa T; Hayashi T; Koga I; Uchida Y Psychiatry; 2007; 70(1):68-79. PubMed ID: 17492913 [TBL] [Abstract][Full Text] [Related]